02PDE2019
Phase II, Double blind, Randomized, Placebo controlled, Parallel group, Trial to Explore Efficacy, safety and pharmacokinetics of CPL500036 (PDE10a inhibitor) in Patients With an Acute Exacerbation of Schizophrenia